Literature DB >> 29616296

PSMA-PET guided hook-wire localization of nodal metastases in prostate cancer: a targeted approach.

Emma Clarebrough1,2, Catriona Duncan3,4, Daniel Christidis2,5, Alain Lavoipierre6, Nathan Lawrentschuk5,7,8,9.   

Abstract

Prostate Specific Membrane Antigen Positron Emission Tomography/Computed Tomography (PSMA-PET/CT) has increased the sensitivity and specificity of imaging to identify metastatic prostate cancer in the group of patients with early biochemical recurrence when compared to conventional imaging. In patients who develop biochemical recurrence of prostate cancer following surgical resection, salvage lymph node dissection may reduce prostate specific antigen (PSA) levels and delay the time for commencement of systemic therapies. However, PLND may be an anatomically and technically difficult procedure, particularly with small metastatic diseases which can be problematic for intra-operative identification. We describe the technique using PSMA-PET imaging to pre-operatively localise areas of low-volume nodal metastatic disease with hookwire to allow targeted lymph node dissection with direct visualisation and palpation to ensure adequate clearance of involved nodes.

Entities:  

Keywords:  Hookwire; Image guided surgery; Lymph node metastasis; PET-PSMA scan; Pelvic lymph node dissection; Prostate cancer

Mesh:

Substances:

Year:  2018        PMID: 29616296     DOI: 10.1007/s00345-018-2282-y

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  20 in total

1.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Authors:  Pia Bader; Fiona C Burkhard; Regula Markwalder; Urs E Studer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

2.  How many lymphadenectomies does it take to cure one patient?

Authors:  Eric A Klein; Michael Kattan; Andrew Stephenson; Andrew Vickers
Journal:  Eur Urol       Date:  2007-09-19       Impact factor: 20.096

3.  Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer.

Authors:  Travis Clark; Dipen J Parekh; Michael S Cookson; Sam S Chang; Ernest R Smith; Nancy Wells; Joseph A Smith
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

4.  Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.

Authors:  Axel Heidenreich; Zoltan Varga; Rolf Von Knobloch
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

Review 5.  Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.

Authors:  Matthew N Simmons; Andrew J Stephenson; Eric A Klein
Journal:  Eur Urol       Date:  2007-01-12       Impact factor: 20.096

6.  Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.

Authors:  Alberto Briganti; Felix K-H Chun; Andrea Salonia; Nazareno Suardi; Andrea Gallina; Luigi Filippo Da Pozzo; Marco Roscigno; Giuseppe Zanni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2006-08-31       Impact factor: 20.096

7.  Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006.

Authors:  Michael Musch; Virgilijus Klevecka; Ulla Roggenbuck; Darko Kroepfl
Journal:  J Urol       Date:  2008-01-22       Impact factor: 7.450

Review 8.  Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.

Authors:  Firas Abdollah; Alberto Briganti; Francesco Montorsi; Arnulf Stenzl; Christian Stief; Bertrand Tombal; Hein Van Poppel; Karim Touijer
Journal:  Eur Urol       Date:  2014-03-26       Impact factor: 20.096

9.  Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer.

Authors:  Mohamad E Allaf; Ganesh S Palapattu; Bruce J Trock; H Ballentine Carter; Patrick C Walsh
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

10.  Diagnostic Value of Hook Wire Localization Technique for Non-Palpable Breast Lesions.

Authors:  Gokhan Demiral; Metin Senol; Baris Bayraktar; Hasan Ozturk; Yahya Celik; Salih Boluk
Journal:  J Clin Med Res       Date:  2016-03-20
View more
  4 in total

Review 1.  PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics.

Authors:  R S Eapen; T C Nzenza; D G Murphy; M S Hofman; M Cooperberg; N Lawrentschuk
Journal:  World J Urol       Date:  2018-10-29       Impact factor: 4.226

Review 2.  Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer.

Authors:  Shankar Siva; Cristian Udovicich; Ben Tran; Homi Zargar; Declan G Murphy; Michael S Hofman
Journal:  Nat Rev Urol       Date:  2020-01-14       Impact factor: 14.432

Review 3.  Navigating systemic therapy for metastatic castration-naïve prostate cancer.

Authors:  E M Kwan; I A Thangasamy; J Teh; O Alghazo; N J Sathianathen; N Lawrentschuk; A A Azad
Journal:  World J Urol       Date:  2020-01-02       Impact factor: 4.226

Review 4.  Novel PET imaging methods for prostate cancer.

Authors:  Esther Mena; Peter C Black; Soroush Rais-Bahrami; Michael Gorin; Mohamad Allaf; Peter Choyke
Journal:  World J Urol       Date:  2020-07-15       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.